Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Erfan Uddin

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Pharmacology|April 1, 2021
Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1Muhammad Erfan Uddin, Dominique A Garrison, Kyeongmin Kim, et al.
Cancer Research Communications|December 24, 2021
Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A InhibitionEric D Eisenmann, Qiang Fu, Elizabeth M Muhowski, et al.
Clinical Pharmacokinetics|March 27, 2025
Pharmacokinetics and Safety of Navitoclax in Hepatic ImpairmentMaulik Patel, Jalaja Potluri, Thomas Marbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2021
Regulation of OATP1B1 Function by Tyrosine Kinase-mediated PhosphorylationElizabeth R Hayden, Mingqing Chen, Kyle Z Pasquariello, et al.
Molecular Cancer Therapeutics|September 14, 2021
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD-Positive AMLMegan E Zavorka Thomas, Xiyuan Lu, Zahra Talebi, et al.
The Journal of Clinical Investigation|June 3, 2020
Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in miceKevin M Huang, Alix F Leblanc, Muhammad Erfan Uddin, et al.
JCI Insight|June 22, 2023
Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathyYang Li, Thomas Drabison, Mahesh Nepal, et al.
International Journal of Molecular Sciences|August 12, 2022
MATE1 Deficiency Exacerbates Dofetilide-Induced ProarrhythmiaMuhammad Erfan Uddin, Eric D Eisenmann, Yang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Targeting OCT3 attenuates doxorubicin-induced cardiac injuryKevin M Huang, Megan Zavorka Thomas, Tarek Magdy, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Frontiers in Pharmacology|April 1, 2021
Influence of YES1 Kinase and Tyrosine Phosphorylation on the Activity of OCT1Muhammad Erfan Uddin, Dominique A Garrison, Kyeongmin Kim, et al.
Cancer Research Communications|December 24, 2021
Intentional Modulation of Ibrutinib Pharmacokinetics through CYP3A InhibitionEric D Eisenmann, Qiang Fu, Elizabeth M Muhowski, et al.
Clinical Pharmacokinetics|March 27, 2025
Pharmacokinetics and Safety of Navitoclax in Hepatic ImpairmentMaulik Patel, Jalaja Potluri, Thomas Marbury, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 5, 2021
Regulation of OATP1B1 Function by Tyrosine Kinase-mediated PhosphorylationElizabeth R Hayden, Mingqing Chen, Kyle Z Pasquariello, et al.
Molecular Cancer Therapeutics|September 14, 2021
Gilteritinib Inhibits Glutamine Uptake and Utilization in <i>FLT3</i>-ITD-Positive AMLMegan E Zavorka Thomas, Xiyuan Lu, Zahra Talebi, et al.
The Journal of Clinical Investigation|June 3, 2020
Neuronal uptake transporters contribute to oxaliplatin neurotoxicity in miceKevin M Huang, Alix F Leblanc, Muhammad Erfan Uddin, et al.
JCI Insight|June 22, 2023
Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathyYang Li, Thomas Drabison, Mahesh Nepal, et al.
International Journal of Molecular Sciences|August 12, 2022
MATE1 Deficiency Exacerbates Dofetilide-Induced ProarrhythmiaMuhammad Erfan Uddin, Eric D Eisenmann, Yang Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 26, 2021
Targeting OCT3 attenuates doxorubicin-induced cardiac injuryKevin M Huang, Megan Zavorka Thomas, Tarek Magdy, et al.
Pageof 2